Collaboration, License and Option Agreements - Additional Information (Details) - USD ($) $ in Thousands		3 Months Ended		6 Months Ended		36 Months Ended
	Nov. 18, 2021	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024	Dec. 31, 2021	Dec. 31, 2024
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Collaboration Amendment Date						2019-04
Liability to licensor		$ 19,806		$ 19,806			$ 19,806
BeiGene
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Collaboration Amendment Date						2021-11
Upfront Non-Refundable Payment						$ 25,000
Revenues		0	$ 0	0	$ 0
Current portion of deferred revenue	$ 19,800
License termination information, Description	In the event the license is terminated, the liability will be extinguished with no further payment to BeiGene.
Liability to licensor		19,800		19,800			$ 19,800
Context Therapeutics Inc
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Revenues		0	$ 0	0	$ 0
Maximum Potential Aggregate Payments		$ 133,500		$ 133,500